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A B S T R A C T
Contact dermatitis is a very common inflammatory reaction in the skin, causing not only aesthetic problems but
also loss functionality at work. The molecular mechanisms of contact dermatitis induced by chemical irritants
are still unclear. Considering that transient receptor potential channels (TRP) may induce neurogenic in-
flammation and the exacerbation of inflammatory responses, here we investigated the role of transient receptor
potential channel ankyrin type-1 (TRPA1) in skin inflammation evoked by chemical irritants. Ear oedema and
nociceptive responses elicited by the topical application of xylene and toluene were measured in Swiss mice,
wild type and TRPA1 knockout (Trpa1−/−) C57BL/6 mice. Histological analyses were performed in mice sub-
jected to the ear oedema assay. Topical application of xylene and toluene in the mouse ear induced an ede-
matogenic response (0.113 ± 0.008mm and 0.067 ± 0.011mm), compared to vehicle (0.008 ± 0.008mm),
assessed by ear thickness measurements and histological analyses. These responses were prevented by topical
pretreatment with a selective TRPA1 antagonist, HC-030031 (% inhibition: xylene 36.8 ± 9.4% and toluene
50.7 ± 11.0%), and by the genetic deletion of TRPA1 ((% inhibition: xylene 66.6 ± 16.7% and toluene
75 ± 0%). In addition, the topical application of xylene and toluene to the mouse paw elicited nociceptive
responses, which were significantly reduced by oral treatment with HC-030031 ((% of inhibition: 84.9 ± 1.3%
and 27.1 ± 8.0%, respectively); nociceptive responses were almost completely abolished in Trpa1−/−mice. Our
data suggest that the activation of TRPA1 could be involved in some of the symptoms of irritant-mediated
contact dermatitis, such as oedema, pain and neurogenic inflammation.
1. Introduction
Nowadays, due to increasing exposure to chemical agents and en-
vironmental pollutants, the number of people developing inflammatory
reactions in the skin has increased. Most of these are clinically de-
scribed as contact dermatitis, which can cause not only aesthetic pro-
blems, but also loss functionality at work (Kaplan et al., 2012). Epi-
demiological studies show that contact dermatitis accounts for 50% of
all occupational diseases in the United States, and is the fourth leading
cause of work-related disability (Cao and Taylor, 2008; Ngo and
Maibach, 2010). The incidence varies according to the risk of exposure
of the population to chemical agents, and is higher in chemical industry
workers, household workers, painters and hairdressers, among others
(Sasseville, 2008).
Both types of contact dermatitis, i.e. irritant-mediated and allergic,
are caused by dermal exposure to chemical agents found in detergents,
solvents, insecticides, beauty and house cleaning products (Cao and
Taylor, 2008). While the allergic reaction results from an immune
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response triggered in the epidermis and dermis after a previous sensi-
tisation (Cao and Taylor, 2008), irritant-mediated contact dermatitis is
caused by chemical agents that directly irritate the skin (Sasseville,
2008; Ngo and Maibach, 2010). Currently, a family of channels known
as transient receptor potential channels (TRPs) are considered to be
molecular integrators of a large number of noxious chemical stimuli
(Boonen et al., 2017). This receptor family has been studied with great
interest in several pathologies including skin inflammation (for a re-
view, see Caterina and Pang, 2016). Among these receptors, we high-
light the transient receptor potential channels ankyrin type-1 (TRPA1).
TRPA1 channels are activated by pungent chemicals such as
horseradish, mustard and cinnamon oils, temperatures less than or
equal to 17 °C, endogenous inflammatory mediators, as well as two α,β-
unsaturated aldehydes (acrolein and crotonaldehyde) generated from
the combustion process of cigarette smoking and petrochemical fuels
(Bautista et al., 2006; Andrè et al., 2008; Nilius et al., 2012). TRPA1 is
expressed in primary sensory fibers and non-neuronal cells such as
keratinocytes (Atoyan et al., 2009; Bíró and Kovács, 2009). Some stu-
dies have demonstrated that TRPA1 is involved in inflammatory skin
symptoms such as erythema, pain and heat hyperalgesia (Silva et al.,
2011; Nilius et al., 2012; Brederson et al., 2013). For example, che-
micals used in the manufacturing sector, i.e. xylene and formaldehyde,
when topically applied to the skin or injected via the intraplantar route,
respectively, result in nociception in mice via TRPV1 and TRPA1 acti-
vation (McNamara et al., 2007; Sándor et al., 2009; Tian et al., 2009).
In addition, it has also been reported that toluene diisocyanate, a ha-
zardous irritant used in paints and foams, causes sensory nerve acti-
vation in vitro via TRPA1 gating (Taylor-Clark et al., 2009). However,
whether the activation of TRPs, in particular TRPA1, is essential to the
development of inflammatory processes, pain and other symptoms ob-
served during irritative contact dermatitis caused by these volatile or-
ganic compounds remains unclear. In this context, we investigated the
role of TRPA1 in the cutaneous inflammatory responses evoked by
chemical irritants such as xylene and toluene after topical application to
the skin.
2. Material and methods
2.1. Animals
Experiments were performed on adult male Swiss mice (25–30 g)
and wild type (Trpa1+/+) or Trpa1-deficient (Trpa1−/−B6; 129P-
Trpa1tm1Kykw/J) mice generated in heterozygous animals on a
C57BL/6 background (Jackson Laboratories, Bar Harbor, Maine, USA).
Animals were maintained in standard housing conditions (12 h light/
dark cycle, lights on at 6 a.m., food and water ad libitum in a climati-
cally controlled environment). The experimental procedures were per-
formed according to the ARRIVE guidelines for reporting experiments
involving animals (Kilkenny et al., 2013) and with the standards set in
the directives for animal care in Brazilian law n°11.794/2008. All
protocols employed have been approved by the Ethics Committee of the
Federal University of Rio Grande do Norte (Protocol n°: 023/2010) and
Federal University of Paraná (Protocol n°: 698), except for the experi-
ments with Trpa1+/+ or Trpa1−/−mice. These were conducted at the
University of Florence (research permit #204/2012-B) in conformity
with the European Communities Council (ECC) guidelines for animal
care procedures and Italian legislative application (DL 116/92) of the
ECC directive (86/609/EEC).
2.2. Drugs and reagents
The TRPA1 antagonist 1,2,3,6-Tetrahydro-1,3-dimethyl-N-[4-(1-me-
thylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide, 2-(1,3-Dimethyl-2,6-
dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide
(HC-030031) was synthesised and purified as previously described (Andrè
et al., 2008) and the structure of the compound was assigned by H-NMR
and mass spectroscopy (final purity>98%) determined by RP-HPLC. To-
luene and xylene were purchased from Sigma (St. Louis, MO, USA). All
drugs used topically were dissolved in acetone immediately prior to use.
HC-030031 was prepared in 0.9% NaCl containing 5% dimethylsulphoxide
plus 5% Tween 80 for intragastric administration. The solutions were di-
luted on the day of the experiment immediately before use.
2.3. Volatile chemical irritant-induced ear oedema
Oedema induced by the topical application of chemical irritants was
measured as an increase in ear thickness. The chemical irritants were
pipetted directly onto the ears of the mice. Ear thickness was assessed
with an electronic digital micrometer (Starrett Series 734) applied near
the tip of the ear distal to the cartilaginous ridges; the difference in
thickness between the basal measurement and after challenge was
calculated (Silva et al., 2011). To minimise variation, a single in-
vestigator performed the measurements and the values were recorded
in mm. Ear thickness was measured before and until 120min after the
topical application of xylene (100%/20 μl/ear), toluene (100%/20 μl/
ear) or their vehicle (acetone, 20 μl/ear) onto the right ear.
2.4. Involvement of the TRPA1 receptor in the edematogenic response
induced by volatile chemical irritants
Separate groups of animals were topically pretreated with the
TRPA1 selective antagonist HC-030031 (300 nmol/20 μl/ear) (Silva
et al., 2011) or its vehicle (acetone, 20 μl/ear) 15min before challenge
with the organic compounds. Ear thickness was measured before and
30min after the topical application of xylene (100%/20 μl/ear), to-
luene (100%/20 μl/ear) or vehicle (acetone, 20 μl/ear) to the right ear.
In another set of experiments, oedema induced by the topical applica-
tion of organic compounds in wild type and Trpa1−/−mice was eval-
uated until 120min after exposure.
2.5. Histology
Histological changes were evaluated in ear samples from mice
pretreated with the topical TRPA1 antagonist HC-030031 (300 nmol/
20 μl/ear) or vehicle in Trpa1 wild type and Trpa1−/−mice, challenged
with the organic compounds. Thirty min after the induction of oedema
by xylene or toluene, mice were euthanised with thiopental (100mg/
kg, intraperitoneal) and ear tissues were removed and fixed in alfac
solution (16:2:1 mixture of 80% ethanol, 40% formaldehyde and glacial
acetic acid). Each sample was embedded in paraffin wax, sectioned at
5 μm and stained with haematoxylin-eosin. A representative area was
selected for qualitative light microscopic analysis of the inflammatory
cellular response with a 40× objective lens (Recio et al., 2000). These
analysis were carried out by using imagej program. To minimise sources
of bias, the investigator analysed the specimens blindly.
2.6. Measurement of behavioural nociceptive responses
In this study, we also investigated whether xylene or toluene could
induce acute nociception after applying irritant compounds directly to
mouse skin. Briefly, animals were firstly individually placed in trans-
parent glass chambers for 1 h of acclimation. After the adaptation
period, xylene (30, 50, 100%/20 μl/paw) or toluene (30, 50, 100%/20
μl/paw) was topically applied (using a Gilson P100 pipette) onto the
plantar surface of the right hind paw. Immediately after the topical
application, mice were gently introduced into the chamber for the
evaluation of the acute nociceptive response. The amount of time spent
licking the exposed hind paw for 5min after chemical irritant appli-
cation was recorded with a chronometer and was considered a measure
of acute nociceptive behaviour.
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2.7. Involvement of the TRPA1 receptor in volatile chemical irritant-induced
nociceptive responses
To assess the role of the TRPA1 receptor in the nociceptive response,
mice received a single oral dose of a TRPA1 antagonist HC-030031
(100mg/kg; intragastric) (Eid et al., 2008) or vehicle. Sixty min later,
xylene (50%/20 μl) or toluene (50%/20 μl) was applied to the right
hind paw and the index of the nociceptive response was evaluated for a
period of 5min. In another set of experiments, xylene (50%/20 μl) or
toluene (50%/20 μl) was applied to the right hind paw of wild type and
Trpa1−/−mice and the nociceptive response was evaluated for a period
of 5min.
2.8. Statistical analysis
Data are reported as the mean ± standard error of the mean
(S.E.M.) of at least 4 animals per group. The statistical analysis was
assessed by the unpaired two-tailed Student's t-test (to evaluate statis-
tical significance between two groups) or by repeated measures two-
way analysis of variance (ANOVA) followed by Bonferroni's multiple
comparison post hoc test. These evaluations were carried out using
GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA). Values of
P≤0.05 were considered to be statistically significant.
3. Results
3.1. Effect of topical of xylene or toluene application on ear oedema
Topical application of xylene (100%/20 μl/ear) and toluene (100%/
20 μl/ear) induced ear oedema in Swiss mice. The peak of the edema-
togenic response was observed at 30min (0.113 ± 0.008mm and
0.067 ± 0.011mm, respectively) when compared to vehicle
(0.008 ± 0.008mm) (Fig. 1A, B).
3.2. Effect of pharmacological blockade and genetic deletion of TRPA1 on
ear oedema induced by xylene and toluene
In Swiss mice, ear oedema evoked by xylene (100%/20 μl/ear) and
toluene (100%/20 μl/ear) was reduced (36.8 ± 9.4% and
50.7 ± 11.0%, respectively) by pretreatment (local application) with
the selective TRPA1 antagonist HC-030031 (300 nmol/20 μl/ear,
15min prior) (Fig. 2A, B). In addition, in Trpa1−/−mice, the ear oe-
dema induced by xylene and toluene was strongly reduced
(66.6 ± 16.7% and 75 ± 0%, respectively) (calculated on the peak of
30min) when compared with wild type mice (Fig. 3A, B).
3.3. Histological findings
Cross-sections of mouse ears collected 30min after being xylene or
toluene challenge showed differences in the thickness of the histological
structures, when compared to vehicle-treated mice (Fig. 4A,B,D,E).
Observations performed with the 40× objective revealed an edema-
togenic response, mainly between the skin and the cartilage. In con-
trast, pretreatment with the TRPA1 antagonist HC-030031 prevented
the ear oedema induced by both chemical irritants (Fig. 4 C,F).
Increased mouse ear thickness was observed in wild type mice after
a single topical application of the chemical irritants (Figs. 5–6). How-
ever, no histological alterations were observed in Trpa1−/−mice chal-
lenged with xylene (Fig. 5) and toluene (Fig. 6).
3.4. Nociceptive response induced by xylene or toluene application to the
mouse paw
The topical application of xylene (50 and 100%/20 μl/paw) or to-
luene (50 and 100%/20 μl/paw) on the plantar surface of the right hind
paw of Swiss mice induced licking reactions in a dose-dependent
manner, characteristic of a painful sensation (Fig. 7A, B).
3.5. Effects of pharmacological and genetic blockade of the TRPA1 receptor
on xylene or toluene-induced nociceptive responses
Xylene (50%/20 μl/paw) and toluene (50%/20 μl/paw) evoked
nociceptive responses were significantly reduced (% of inhibition:
84.9 ± 1.3% and 27.1 ± 8.0%, respectively) by oral pretreatment
with the TRPA1 antagonist HC-030031 (100mg/kg, 60min prior the
chemical application) in Swiss mice (Fig. 8A, B). Furthermore, the no-
ciceptive response elicited by the topical application of xylene (50%/20
Fig. 1. Ear oedema induced by volatile chemical irritants. Time-course of ear
oedema induced by topical application xylene (100%/20 μl/ear) and toluene
(100%/20 μl/ear) in mice. The effects of these chemical irritants were mea-
sured 30, 60, 90 and 120 min after the administration of chemical irritants and
were expressed as the change in ear thickness. Each point represents the
mean ± S.E.M. for 8 animals. . *P < 0.05 vs. vehicle (Student's t-test).
Fig. 2. Effect of TRPA1 receptor antagonist on the edematogenic responses
induced by volatile chemical irritants. HC-030031 topical pretreatment was
performed 15 min before the topical application of xylene (100%/20 μl/ear; A)
or toluene (100%/20 μl/ear; B). Ear oedema was measured 30 min after ad-
ministration of each chemical irritant and were expressed as the change in ear
thickness. Each column represents the mean ± S.E.M. for 8 animals.
*P < 0.05 vs. vehicle plus xylene or toluene (Veh1) (one-way ANOVA followed
by Bonferroni's test).
Fig. 3. Ear oedema induced by topical application of volatile chemical irritants
in wild type (Trpa1+/+) or TRPA1-deficient mice (Trpa1−/−). Ear oedema was
measured 30, 60, 90 and 120 min after the topical administration of xylene
(100%/20 μl/ear; A) or toluene (100%/20 μl/ear; B) and are expressed as the
change in ear thickness. Each point represents the mean ± S.E.M. for at least 5
animals. *P < 0.05 vs. Trpa1+/+ (Student's t-test).
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μl/paw; 32.0 ± 5.1 s) and toluene (50%/20 μl/paw; 17.4 ± 2.3 s) was
suppressed in mice with genetic deletion of TRPA1 (0.3 ± 0.1 s and
2.4 ± 0.8 s, respectively) as compared to wild type mice (Fig. 9A, B).
4. Discussion
Exposure to noxious chemical compounds may occur throughout
multiple routes, including dermal contact. Xylene and toluene are
common pollutants in the plastic, chemical and leather industries. Skin
contact with chemical substances may result in local diseases such as
irritant contact dermatitis, the most common type of occupational skin
disorder, or allergic dermatitis (Sasseville, 2008). The present study
shows that the topical application of chemical irritants, i.e. xylene and
toluene, induces robust and long-lasting ear oedema in mice.
By focusing on the role played by TRPA1 signalling in the mediation
of skin inflammation induced by xylene and toluene, here we show
through ear thickness measurements and histological analyses that
pharmacological and genetic blockade of TRPA1 significantly inhibited
xylene- and toluene-induced ear oedema. Thus, these findings suggest
that some volatile irritant compounds, after contact with the skin,
promote vascular reactions mediated by TRPA1 receptor signalling. The
role of TRPA1 in skin inflammation has been previously reported by our
Fig. 4. Representative light microphotograph
and graphic of the effects of TRPA1 antagonist
on xylene and toluene-induced ear edema in
mice. A thin section was obtained from ear
tissue of mice pretreated with HC-030031 (300
nmol/20 μl/ear) or vehicle (acetone, 20 μl/ear)
30 min after the topical application of xylene
(100%/20 μl/ear), toluene (100%/20 μl/ear) or
vehicle (Veh, acetone, 20 μl/ear) (hematoxylin-
eosin staining) x40. (A) Veh- Veh; (B) Veh-
Xylene; (C) HC-030031-Xylene; (D) Veh-
Toluene; (E) HC-030031-Toluene; (F)
Representative graphic of light micro-
photograph of the effects of TRPA1 antagonist
on xylene and toluene-induced ear edema in
mice. Each column represents the
mean ± S.E.M. for 8 animals. *P < 0.05 vs.
xylene or toluene (one-way ANOVA followed by
Bonferroni's test).
Fig. 5. Representative light microphotograph and graph indicating the effect of
genetic deletion TRPA1 receptor on xylene-induced ear oedema in mice. Thin
sections were obtained from the ear tissue of mice Trpa1+/+ and Trpa-/-30 min
after the topical application of xylene or vehicle (Veh, 20 μl/ear) (haematox-
ylin-eosin staining ×40). *P < 0.05 vs. vehicle (veh), §P < 0.05 vs. xylene,
(one-way ANOVA followed by Bonferroni's test).
Fig. 6. Representative light microphotograph and graph indicating the effect of
genetic deletion TRPA1 receptor on toluene-induced ear oedema in mice. Thin
sections were obtained from ear tissue of mice Trpa1+/+ and Trpa1−/−30 min
after the topical application of toluene or vehicle (Veh, acetone, 20 μl/ear)
(haematoxylin-eosin staining ×40). *P < 0.05 vs. vehicle (veh), §P < 0.05
vs. toluene, (one-way ANOVA followed by Bonferroni's test).
Fig. 7. Nociceptive responses induced by volatile chemical irritants.
Nociceptive dose-response curves induced by topical application of xylene
(30–100%/20 μl/paw; A) or toluene (30–100%/20 μl/paw; B) in the right hind
paw of mice. Nociception time was assessed by recording the time spent
evoking nociceptive responses during 5 min of observation immediately after
exposure to chemical irritants. Each point represents the mean ± S.E.M. for 8
animals per group. *P < 0.05 compared to the xylene 30% or toluene 30%
group (one-way ANOVA followed by Bonferroni's test).
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research group (Silva et al., 2011). We showed that the topical ad-
ministration to the mouse ear of the TRPA1 receptor agonist cinna-
maldehyde promoted inflammatory responses with oedema formation,
which was inhibited by pre-exposure to the TRPA1 antagonist HC-
030031 (Silva et al., 2011). To reinforce the role of TRPA1 in skin
disorders, it has been demonstrated that this channel is expressed in
many non-neuronal cell types, such as mast cells, keratinocytes (Bíró
and Kovács, 2009) and melanocytes (Bellono et al., 2013), and in
sensory nerves, where it works as a nociceptive sensor (Atoyan et al.,
2009).
It was interesting to note that, besides oedema and erythema, other
relevant clinical manifestations mentioned by patients after dermal
exposure to chemical irritants are pain sensations and itching at the site
of injury (Ngo and Maibach, 2010). We also observed that xylene and
toluene contact with the skin induced an acute nociceptive response. In
fact, the topical application of xylene and toluene directly to the mouse
paw was sufficient to elicit nociceptive responses, as assessed by an
increased amount of time spent licking the treated paw. Taken together,
the sensory and vascular manifestations observed after the application
of xylene and toluene to the ear and paw of mice mimic the main
symptoms of irritant contact dermatitis.
In the present study, we also observed that both pretreatment with
the TRPA1 antagonist HC-030031 and genetic deletion of the TRPA1
receptor significantly inhibited xylene-and toluene-induced nociceptive
responses when topically applied to the mouse paw. A growing body of
evidence supports a role for TRPA1 in mediating pain and pruritic re-
sponses caused by several exogenous noxious stimuli (Oh et al., 2013;
Wilson et al., 2013; Chen and Hackos, 2015). However, Sándor et al.
(2009) employed a similar method to that used in this study and re-
ported that xylene-induced nociception is mediated by the TRPV1 re-
ceptor signalling. These authors showed that pharmacological and ge-
netic blockade of TRPV1 partially prevented xylene-induced
nociceptive responses (Sándor et al., 2009).
It is interesting to note that a close relationship between TRPA1 and
TRPV1 has already been reported. Both TRPV1 and TRPA1 are co-ex-
pressed in a large subset of sensory nerves and, using transient co-ex-
pression of these two receptors in Chinese hamster ovary cells,
Staruschenko et al. (2010) demonstrated a direct interaction between
TRPV1 and TRPA1, resulting in heterotetramer formation by these two
ion channels. Recently, it has also been demonstrated that Ca2+ influx
through TRPV1 opening may increase the sensitivity of the TRPA1
channel (Hsu and Lee, 2015). Therefore, it is possible that both TRPA1
and TRPV1, working synergistically, can mediate the cutaneous in-
flammatory response caused by some volatile irritant chemical com-
pounds.
5. Conclusion
In conclusion, we have shown that the activation of TRPA1 could be
involved in some of the symptoms of irritant contact dermatitis, such as
pain, neurogenic inflammation and possibly itching induced by the
topical exposure of some volatile chemical irritants. The present data
also support a role for TRPA1 antagonists as innovative drugs for to-
pical pharmacological intervention during skin inflammation.
However, other studies are required to further clarify the role of other
TRP receptors in inflammatory skin reactions.
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